Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Maneesh Jain, Martin Coyne II, Glenn Muir


Maneesh Jain joined startup Butterfly Network earlier this year as president and COO. Butterfly Network plans to integrate novel devices with the cloud and learning applications for diagnostic and therapeutic imaging applications.

Previously, Jain was vice president of marketing and business development at Ion Torrent. In addition, he cofounded ParAllele BioScience, which merged with Affymetrix in 2005; as well as Auriphex, which merged with Illumina in 2009.

RainDance Technologies had appointed Martin Coyne II and Glenn Muir to its board of directors.

Coyne retired from Eastman Kodak in July 2003. He had served there as president of health imaging, president of the commercial business group, and most recently as executive VP of Eastman Kodak and group executive of the photography group. He is chairman of the board of RockTech, a privately held SaaS business, and sits on the board of Akamai.

Muir most recently served as CFO of Hologic, a position he held from 1992 to May 2014. He also was on Hologic's board of directors. Muir also is the audit committee chair at ReWalk Robotics.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.